Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Consumer News Ftc Report Says Pharmacy Benefit Managers Keep Drug Prices High

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Ftc Report Says Pharmacy Benefit Managers Keep Drug Prices High is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News Ftc Report Says Pharmacy Benefit Managers Keep Drug Prices High | RobinsPost News & Noticias

Prescription drug middlemen fight FTC oversight at Eighth Circuit


The pharmacy benefit managers claim the government agency violates due process rights by acting as investigator, prosecutor and judge in its own administrative court. Read More

How Trump’s FTC Can Keep Drug Prices Down for Working Americans


Joseph R. Pitts served as a member of the U.S. House from Pennsylvania. He chaired the House Energy & Commerce Committee’s Subcommittee on Health. How do leading retailers like Amazon and Walmart ... Read More

Eighth Circuit Hears Challenge to FTC Action Over Insulin Costs


Judges on a federal appeals court questioned pharmacy benefit managers Wednesday over the merits of their case against the Federal Trade Commission, which seeks to halt the agency’s internal ... Read More

Why Mark Cuban Is Wrong About Pharmacy Benefit Managers


Pharmacy benefit managers (PBMs) are back in the crosshairs. PBMs negotiate drug prices down on behalf of consumers and insurers – to the ire of ... Read More

Big Rebates Make High Drug Prices Look Like Savings. Here’s The Fix


NEW YORK, NEW YORK - JULY 23: Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024, in New York City. In the U.S. drug market, higher list prices can paradoxically ... Read More

Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’


Billionaire venture capitalist Mark Cuban has not shied away from blasting President Donald Trump’s policy decisions, but he said Trump’s latest move just might work. The president announced on ... Read More

Arkansas legal showdown with PBMs could reshape state's prescription drug market in 2026


Mount St. Mary Academy in Little Rock, Arkansas, is celebrating its 175th anniversary, marking a significant milestone in its history as the state's oldest high Pulaski County Sheriff's Office ... Read More

Cigna Unit Sells Generic Drugs at Higher Prices, Report Says


A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus